TECH
$76.27
Revenue | $289.46Mn |
Net Profits | $33.6Mn |
Net Profit Margins | 11.61% |
Bio-techne Corp.’s revenue jumped 4.52% since last year same period to $289.46Mn in the Q3 2024. On a quarterly growth basis, Bio-techne Corp. has generated -5.44% fall in its revenue since last 3-months.
Bio-techne Corp.’s net profit fell -34.11% since last year same period to $33.6Mn in the Q3 2024. On a quarterly growth basis, Bio-techne Corp. has generated -17.22% fall in its net profits since last 3-months.
Bio-techne Corp.’s net profit margin fell -36.96% since last year same period to 11.61% in the Q3 2024. On a quarterly growth basis, Bio-techne Corp. has generated -12.46% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.38 |
EPS Estimate Current Year | 0.38 |
Bio-techne Corp.’s earning per share (EPS) estimates for the current quarter stand at 0.38 - a -22.45% fall from last quarter’s estimates.
Bio-techne Corp.’s earning per share (EPS) estimates for the current year stand at 0.38.
Earning Per Share (EPS) | 0.42 |
Dividend Per Share (DPS) | 0.08 |
Bio-techne Corp.’s earning per share (EPS) jumped 2.44% since last year same period to 0.42 in the Q3 2024. This indicates that the Bio-techne Corp. has generated 2.44% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Bio-techne Corp. declared 0.08 dividend per share during the earnings announcement for Q3 2024.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-08-22 | 0.49 | 0.49 | 0% |
2024-05-06 | 0.45 | 0.48 | 6.67% |
2024-11-05 | 0.38 | 0.42 | 10.53% |